Experimental Study on Effect of Modified Guilu Erxianjiao Decoction Combined with Cisplatin on Resistance-related Genes and IL-7-mediated Wnt/<italic style="font-style: italic">β</italic>-catenin Signaling Pathway in Mice with Lewis Lung Cancer

Lin SHI; Yuan-yuan HUANG; Bin KE

doi:10.13422/j.cnki.syfjx.20210623

您当前的位置：

首页 >

文章列表页 >

Experimental Study on Effect of Modified Guilu Erxianjiao Decoction Combined with Cisplatin on Resistance-related Genes and IL-7-mediated Wnt/β-catenin Signaling Pathway in Mice with Lewis Lung Cancer

Pharmacology | 更新时间：2021-08-18

- Experimental Study on Effect of Modified Guilu Erxianjiao Decoction Combined with Cisplatin on Resistance-related Genes and IL-7-mediated Wnt/β-catenin Signaling Pathway in Mice with Lewis Lung Cancer
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 27, Issue 18, Pages: 66-72(2021)
- 作者机构：
  
  1.南方医科大学珠江医院，广州 510282
  2.中山大学肿瘤防治中心，广州 510060
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.20210623
  CLC： R22;R242;R2-031;R285.5
- Received：28 October 2020，
  
  Published Online：20 January 2021，
  
  Published：20 September 2021
- 稿件说明：
移动端阅览
师林,黄圆圆,柯斌.加味龟鹿二仙胶汤联合顺铂对Lewis肺癌小鼠耐药相关基因及IL-7介导的Wnt/β-catenin信号通路的影响[J].中国实验方剂学杂志,2021,27(18):66-72.

SHI Lin,HUANG Yuan-yuan,KE Bin.Experimental Study on Effect of Modified Guilu Erxianjiao Decoction Combined with Cisplatin on Resistance-related Genes and IL-7-mediated Wnt/β-catenin Signaling Pathway in Mice with Lewis Lung Cancer[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(18):66-72.
师林,黄圆圆,柯斌.加味龟鹿二仙胶汤联合顺铂对Lewis肺癌小鼠耐药相关基因及IL-7介导的Wnt/β-catenin信号通路的影响[J].中国实验方剂学杂志,2021,27(18):66-72. DOI： 10.13422/j.cnki.syfjx.20210623.

SHI Lin,HUANG Yuan-yuan,KE Bin.Experimental Study on Effect of Modified Guilu Erxianjiao Decoction Combined with Cisplatin on Resistance-related Genes and IL-7-mediated Wnt/β-catenin Signaling Pathway in Mice with Lewis Lung Cancer[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(18):66-72. DOI： 10.13422/j.cnki.syfjx.20210623.

摘要

目的

通过建立气阴两虚型Lewis肺癌小鼠模型，观察加味龟鹿二仙胶汤联合顺铂对Lewis肺癌小鼠免疫功能、耐药相关基因及白细胞介素-7（IL-7）介导的Wnt/

β-

连环蛋白（

-catenin）信号通路的影响，阐明加味龟鹿二仙胶汤的抗癌机制，为其临床应用提供依据。

方法

建立气阴两虚型Lewis肺癌小鼠模型，分为正常组（不造模），模型组（等体积生理盐水），顺铂组（顺铂，2 mg·kg

-1

），中药组（加味龟鹿二仙胶汤，19.63 g·kg

-1

·d

-1

），联合组（加味龟鹿二仙胶汤，19.63 g·kg

-1

·d

-1

+顺铂，2 mg·kg

-1

），每组10只，分别给药，干预21 d。观察小鼠一般情况、脏器指数，计算抑瘤率，流式细胞仪检测CD4

CD25

调节性T细胞（CD4

CD25

Treg），酶联免疫吸附测定法（ELISA）检测血清中细胞因子水平IL-7，实时荧光定量聚合酶链式反应（Real-time PCR）检测肿瘤组织中耐药相关基因P-糖蛋白（P-gp），多药耐药相关蛋白1（MRP1）mRNA的表达水平，蛋白免疫印迹法（Western blot）检测肿瘤组织中Wnt/

-catenin信号通路蛋白表达。

结果

与模型组比较，中药组及联合组摄食量增加，精神状态较好，反应灵敏，体质量增加。与顺铂组比较，联合组胸腺指数、脾脏指数显著升高（

0.01），联合组抑瘤率明显升高（

0.01）。与顺铂组比较，中药组、联合组CD4

CD25

Treg /CD4

明显降低（

0.05，

0.01），中药组、联合组IL-7水平显著升高（

0.01）。与顺铂组比较，中药组、联合组P-gp，MRP1 mRNA表达明显降低（

0.05，

0.01），中药组、联合组Wnt1，

-catenin蛋白表达显著降低（

0.01）。

结论

加味龟鹿二仙胶汤与顺铂联用可明显抑制Lewis肺癌小鼠体内肿瘤的生长，其作用机制可能与其能够解除机体免疫抑制状态，促进机体产生IL-7，调节IL-7介导的Wnt/

-catenin信号通路，减少肺癌组织中耐药相关基因的表达有关。

Abstract

Objective

To observe the effect of modified Guilu Erxianjiao decoction combined with cisplatin on the immune function， resistance-related genes and interleukin-7（IL-7）-mediated Wnt/

-serial protein（

-catenin）signaling pathway in Lewis lung cancer mice by establishing a mouse model of Lewis lung cancer with deficiency of both Qi and Yin. And the anti-cancer mechanism of modified Guilu Erxianjiao decoction was clarified， so as to provide a basis for its clinical application.

Method

A Lewis lung cancer mouse model （type of deficiency of both Qi and Yin） was established. Mice were divided into a normal group （no modeling）， a model group （saline solution）， a cisplatin group （cisplatin， 2 mg·kg

-1

）， a traditional Chinese medicine （TCM） group （modified Guilu Erxianjiao decoction， 19.63 g·kg

-1

·d

-1

）， and a combined group （modified Guilu Erxianjiao decoction， 19.63 g·kg

-1

·d

-1

+ cisplatin， 2 mg·kg

-1

）. The 10 mice in each group were administered separately for 21 days of intervention. The general conditions and organ indexes of mice were observed， and tumor inhibition rate was calculated. CD4

CD25

regulatory T cell （CD4

CD25

Treg） were detected by flow cytometry， the IL-7 level of cytokines in serum was detected by enzyme linked immunosorbent assay（ELISA）， and real-time quantitative polymerase chain reaction（Real-time PCR） was used to detect the gene expression level of drug resistance-related genes P-glycoprotein（P-gp）， and multidrug resistance protein1（MRP1）in tumor tissues. The protein expression of Wnt/

-serial protein（

-catenin）signaling pathway in tumor tissues were detected by Western blot.

Result

In the TCM group and the combined group， the food intake increased， the mental state was better， the response was sensitive， and the body weight increased. Compared with the cisplatin group， the thymus index and spleen index in the combined group were significantly increased （

0.01）， and the tumor inhibition rate of the combined group was significantly increased （

0.01）. Compared with the cisplatin group， the percentage of CD4

CD25

Treg/CD4

in the TCM group and the combined group was significantly reduced （

0.01）， and IL-7 in the TCM group and the combined group was significantly increased （

0.01）. Compared with the cisplatin group， the expressions of P-gp and MRP1 genes in the TCM group and the combined group were significantly reduced （

0.05，

0.01）， and the protein expressions of secretory glycoprotein1（Wnt1）and

-serial protein（

-catenin）in the TCM group and the combined group were significantly reduced （

0.01）.

Conclusion

The combined use of modified Guilu Erxianjiao decoction and cisplatin can significantly inhibit the growth of tumors in mice with Lewis lung cancer， and its mechanism of action may be related to the efficacy of m odified Guilu Erxianjiao decoction in relieving the body's immunosuppressive state， promoting the body to produce IL-7， regulating IL-7-mediated Wnt/

-catenin signaling pathway and reducing the expression of resistance-related genes in lung cancer tissues.

关键词

Keywords

references

QI G ， LI L . Long non-coding RNA PVT1 contributes to cell growth and metastasis in non-small-cell lung cancer by regulating miR-361-3p/SOX9 axis and activating Wnt/beta-catenin signaling pathway ［J］. Biomed Pharmacother ， 2020 ， 126 （ 10 ）： 100 - 110 .

高武，王晓仙，徐宏峰 . 扶正培本法治疗肿瘤的疗效观察与思考［J］. 湖北中医杂志， 2020 ， 42 （ 3 ）： 54 - 55 .

宾东华，李玲，唐宇，等 . 基于中医哲学思维探析龟鹿二仙胶组方及临床运用［J］. 中医杂志， 2020 ， 61 （ 17 ）： 1559 - 1561 .

WANG J ， YING Y Y ， CHEN Z H ， et al . Guilu Erxian glue（龟鹿二仙胶） inhibits chemotherapy-induced bone marrow hematopoietic stem cell senescence in mice may via p16~（INK4a）-Rbhway ［J］. Chin J Integr Med ， 2020 ， 26 （ 11 ）： 819 - 824 .

荆建华 . 加味龟鹿二仙胶汤对Lewis肺癌小鼠C-myc表达及免疫系统影响［J］. 四川中医， 2019 ， 37 （ 4 ）： 47 - 51 .

钟亚珍，林贤雷，陆金华，等 . 龟鹿二仙胶通过调控PD-1表达抑制H22荷瘤小鼠肿瘤生长的研究［J］. 中国现代医生， 2018 ， 56 （ 36 ）： 1 - 5 .

陆金华，钟亚珍，林胜友 . 龟鹿二仙胶含药血清对顺铂培养大鼠T淋巴细胞影响的实验研究［J］. 中国中医药科技， 2018 ， 25 （ 3 ）： 328 - 331 .

陆金华，钟亚珍，王珏，等 . 龟鹿二仙胶含药血清干预大鼠T细胞化疗后自噬的初步研究［J］. 浙江中医药大学学报， 2017 ， 41 （ 7 ）： 612 - 616 .

师林，柯斌，宋朝阳 . 加味龟鹿二仙胶汤对气阴两虚Lewis荷瘤小鼠化疗的减毒增效作用［J］. 中药材， 2014 ， 37 （ 8 ）： 1434 - 1437 .

师林，柯斌，李永浩 . 加味龟鹿二仙胶汤对非小细胞肺癌化疗患者免疫功能的影响［J］. 新中医， 2012 ， 44 （ 8 ）： 74 - 76 .

黄继汉，黄晓晖，陈志扬，等 . 药理试验中动物间和动物与人体间的等效剂量换算［J］. 中国临床药理学与治疗学， 2004 ， 9 （ 9 ）： 1069 - 1072 .

贾方，王秋月，崔文静，等 . 中医药调节非小细胞肺癌免疫逃逸机制的研究进展［J］. 中华中医药杂志， 2019 ， 34 （ 11 ）： 5312 - 5315 .

师林，柯斌，黄圆圆 . 金水相生法在肺癌化疗中的应用探讨［J］. 中华中医药学刊， 2017 ， 35 （ 11 ）： 2780 - 2782 .

KE B ， SHL L ， XU Z ， et al . Flavored Guilu Erxian decoction inhibits the injury of human bone marrow mesenchymal stem cells induced by cisplatin ［J］. Cell Mol Biol ， 2018 ， 64 （ 6 ）： 58 - 64 .

师林，柯斌，黄圆圆，等 . 加味龟鹿二仙胶汤联合顺铂对小鼠Lewis肺癌PI3K/Akt/mTOR通路的影响［J］. 中成药， 2017 ， 39 （ 10 ）： 2148 - 2152 .

师林，柯斌，黄圆圆，等 . 加味龟鹿二仙胶汤联合顺铂对小鼠Lewis肺癌组织、骨髓组织TGF- β 1 /Smad信号通路的影响［J］. 中药材， 2017 ， 40 （ 10 ）： 2419 - 2423 .

ZHOU X ， LIU Z ， LONG T ， et al . Immunomodulatory effects of herbal formula of astragalus polysaccharide （APS）and polysaccharopeptide （PSP）in mice with lung cancer ［J］. Int J Biol Macromol ， 2018 ， doi： 10.1080/08923970802279183 http://dx.doi.org/10.1080/08923970802279183 .

HU X ， GU Y ， ZHAO S ， et al . Elevated circulating CD4（+）CD25（-）Foxp3（+） regulatory T cells in patients with nonsmall cell lung cancer ［J］. Cancer Biother Radiopharm ， 2019 ， 34 （ 5 ）： 325 - 333 .

KE B ， WEI T ， HUANG Y ， et al . Interleukin-7 resensitizes non-small-cell lung cancer to cisplatin via inhibition of ABCG2 ［J］. Mediators Inflamm ， 2019 ， 20 （ 12 ）： 718 - 728 .

SHI L ， XU Z ， YANG Q ， et al . IL-7-Mediated IL-7R-JAK3/STAT5 signalling pathway contributes to chemotherapeutic sensitivity in non-small-cell lung cancer ［J］. Cell Prolif ， 2019 ， 52 （ 6 ）： e12699 .

NING M Y ， CHENG Z L ， ZHAO J . MicroRNA-448 targets SATB1 to reverse the cisplatin resistance in lung cancer via mediating Wnt/beta-catenin signalling pathway ［J］. J Biochem ， 2020 ， 168 （ 1 ）： 41 - 51 .

DENG Q F ， FANG Q Y ， JI X X ， et al . Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/Akt axis ［J］. J Cancer ， 2020 ， 11 （ 12 ）： 3667 - 3674 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Guiqi Yiyuan Ointment Combined with Cisplatin on Mice with Lewis Lung Cancer Through Endoplasmic Reticulum Stress Pathway and Mitochondrial Apoptosis Pathway

Effect of Supplementing Qi and Nourishing Yin on Gastrointestinal Reactions and Quality of Life in Patients with Advanced Lung Cancer after Chemotherapy

Effect of Xiaoshui Formula Combined with Cisplatin on Th17/Treg Immune Balance in Lung Cancer Xenografts in Mice with Pleural Effusion

Related Author

KONG Siqi

LI Jintian

LI Juan

LIANG Jianqing

ZHANG Yi

ZHANG Yue

YUAN Chao

SHI Lin

Related Institution

The Clinical College of Traditional Chinese Medicine， Gansu University of Chinese Medicine

The Key Laboratory of the Ministry of Education of Dunhuang Medicine and Transformation

School of Basic Medicine， Gansu University of Chinese Medicine

Traditional Chinese Medicine Department,Zhujiang Hospital of Southern Medical University

Traditional Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

Experimental Study on Effect of Modified Guilu Erxianjiao Decoction Combined with Cisplatin on Resistance-related Genes and IL-7-mediated Wnt/β-catenin Signaling Pathway in Mice with Lewis Lung Cancer

DOI：10.13422/j.cnki.syfjx.20210623

摘要

Abstract

关键词

Keywords

references